Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Iran has launched a barrage of ballistic missiles at Israel, a move that will dramatically widen the year-old conflict in the Middle East.

Iran launches missile attack on Israel

Breaking news: Iran has launched a barrage of ballistic missiles at Israel, a move that will dramatically widen the year-old conflict in the Middle East.

News reports in Israel indicate that Iran has launched at least 100 missiles at the Jewish State. Israeli air defense systems intercepted a number of the Iranian missiles. There were explosions in Tel Aviv and other Israeli cities.

Subscripion logo

You're seeing a preview of our Premium coverage. Read the full story by subscribing here.

Premium Defense

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.